NEW YORK (AP) -- Chinese drugmaker Biostar Pharmaceuticals Inc. on Tuesday said it named Deyin "Bill" Chen as its new chief financial officer.
The Xianyang-based company said Chen was named CFO on Thursday. He replaces Elaine Zhao, who resigned on Wednesday. Biostar said Chen's previous experience includes advisory positions at IBM Global Services and Ernst & Young. Most recently he was an independent adviser involved in private equity fundraising and providing services related to fundraising and mergers and acquisitions.
The company's main product is an over-the-counter hepatitis B drug called Xin-Aoxing Oleanolic Acid Capsules.
Biostar shares rose 4 cents to $2.65 in morning trading.
